Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of renal cell carcinoma (disease) that is caused by an inherited modification of the individual's genome.
Biomarker and diagnostic research for hereditary renal cell carcinoma has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
102 publications have been identified in PubMed for hereditary renal cell carcinoma. Research spans Review / Meta-Analysis (38%), Case Report / Case Series (21%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 39 | 38% |
Data assembled from 3 of 12 sources · Last updated Oct 4, 2026, 6:17 AM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Patient case studies |
21 |
21% |
Disease patterns and progression | 18 | 18% |
Testing and diagnosis research | 8 | 8% |
Laboratory research | 8 | 8% |
Clinical study results | 4 | 4% |
Other research | 3 | 3% |
New treatment approaches | 1 | 1% |
Re C (2026). [PMID: 41231040](https://pubmed.ncbi.nlm.nih.gov/41231040/). *BJU international*. [Clinical Trial Publication]
Miranda M (2026). [PMID: 41518461](https://pubmed.ncbi.nlm.nih.gov/41518461/). *Familial cancer*. [Review / Meta-Analysis]
Bartoš V (2026). [PMID: 42082369](https://pubmed.ncbi.nlm.nih.gov/42082369/). *Klin Onkol*. [Case Report / Case Series]
Orsatti A (2026). [PMID: 41591977](https://pubmed.ncbi.nlm.nih.gov/41591977/). *Pathobiology : journal of immunopathology, molecular and cellular biology*. [Review / Meta-Analysis]
Senthamizh T (2026). [PMID: 38753939](https://pubmed.ncbi.nlm.nih.gov/38753939/). *Unknown Journal*. [Other]
Liu T (2026). [PMID: 41856557](https://pubmed.ncbi.nlm.nih.gov/41856557/). *J Med Genet*. [Epidemiology / Natural History]
Bertrand J (2026). [PMID: 41811690](https://pubmed.ncbi.nlm.nih.gov/41811690/). *Nephrologie & therapeutique*. [Case Report / Case Series]
Sheikhy A (2026). [PMID: 40952492](https://pubmed.ncbi.nlm.nih.gov/40952492/). *Abdominal radiology (New York)*. [Diagnostic / Biomarker]
Valdés Vásquez JF (2026). [PMID: 42118473](https://pubmed.ncbi.nlm.nih.gov/42118473/). *Int Urol Nephrol*. [Review / Meta-Analysis]
Cai Q (2026). [PMID: 41544190](https://pubmed.ncbi.nlm.nih.gov/41544190/). *International journal of surgical pathology*. [Diagnostic / Biomarker]